Ausdal Financial Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-13,590
| Closed | -$1.04M | – | 470 |
|
|
2023
Q1 | $1.04M | Sell |
13,590
-54
| -0.4% | -$4.12K | 0.14% | 160 |
|
|
2022
Q4 | $1.13M | Buy |
13,644
+49
| +0.4% | +$4.07K | 0.16% | 147 |
|
|
2022
Q3 | $1.08M | Sell |
13,595
-2,169
| -14% | -$172K | 0.17% | 146 |
|
|
2022
Q2 | $1.17M | Buy |
15,764
+2,160
| +16% | +$160K | 0.18% | 154 |
|
|
2022
Q1 | $1.22M | Buy |
13,604
+5,630
| +71% | +$506K | 0.17% | 159 |
|
|
2021
Q4 | $893K | Buy |
7,974
+11
| +0.1% | +$1.23K | 0.12% | 194 |
|
|
2021
Q3 | $1M | Hold |
7,963
| – | – | 0.15% | 173 |
|
|
2021
Q2 | $1.08M | Hold |
7,963
| – | – | 0.16% | 166 |
|
|
2021
Q1 | $1.08M | Buy |
7,963
+16
| +0.2% | +$2.17K | 0.18% | 150 |
|
|
2020
Q4 | $1.12M | Buy |
7,947
+29
| +0.4% | +$4.08K | 0.22% | 134 |
|
|
2020
Q3 | $882K | Sell |
7,918
-65
| -0.8% | -$7.24K | 0.21% | 128 |
|
|
2020
Q2 | $894K | Buy |
7,983
+13
| +0.2% | +$1.46K | 0.3% | 96 |
|
|
2020
Q1 | $757K | Buy |
7,970
+1,179
| +17% | +$112K | 0.27% | 99 |
|
|
2019
Q4 | $622K | Buy |
6,791
+774
| +13% | +$70.9K | 0.18% | 138 |
|
|
2019
Q3 | $459K | Sell |
6,017
-76
| -1% | -$5.8K | 0.16% | 167 |
|
|
2019
Q2 | $529K | Sell |
6,093
-1,508
| -20% | -$131K | 0.2% | 135 |
|
|
2019
Q1 | $688K | Buy |
+7,601
| New | +$688K | 0.28% | 92 |
|
|
2018
Q4 | – | Sell |
-3,816
| Closed | -$366K | – | 406 |
|
|
2018
Q3 | $366K | Sell |
3,816
-316
| -8% | -$30.3K | 0.1% | 238 |
|
|
2018
Q2 | $393K | Buy |
4,132
+509
| +14% | +$48.4K | 0.12% | 227 |
|
|
2018
Q1 | $318K | Sell |
3,623
-220
| -6% | -$19.3K | 0.11% | 237 |
|
|
2017
Q4 | $326K | Buy |
+3,843
| New | +$326K | 0.12% | 236 |
|
|
2016
Q3 | – | Sell |
-4,903
| Closed | -$265K | – | 279 |
|
|
2016
Q2 | $265K | Buy |
+4,903
| New | +$265K | 0.14% | 182 |
|
|
2016
Q1 | – | Sell |
-36
| Closed | -$3K | – | 1029 |
|
|
2015
Q4 | $3K | Buy |
+36
| New | +$3K | ﹤0.01% | 1183 |
|